Hare
HomeInsights

INDUSTRY:

Pharma

TOPIC:

Products & Services, Business & People, Manufacturers & Providers

TITLE:

EMA: New treatment for patients with soft tissue sarcoma

BRIEF:

The European Medicines Agency (EMA) has recommended granting a conditional marketing authorisation to Lartruvo (olaratumab) for the treatment of adults with soft tissue sarcoma, a rare type of cancer.

LEGAL IMPLICATIONS:

BUSINESS IMPLICATIONS:

Special Report

In an unexpected move, just before the end of 2011, ...

Case Study

Improving expenditure efficiency has been, for a ver...

Your Portal Link to Mass Media Universe.

Valuable Quarterly Romanian Market Analysis.

Ask the analyst

Tailor-made advice for you

Feature Company